Literature DB >> 12673888

Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies.

Z Mackiewicz1, M Hukkanen, D Povilenaite, A Sukura, J E Fonseca, I Virtanen, Y T Konttinen.   

Abstract

OBJECTIVE: To analyse the expression of factors potentially involved in skeletal muscle degeneration and regeneration in dermatomyositis (DM), systemic sclerosis (SSc), polymyositis (PM), systemic lupus erythematosus (SLE) and non-inflammatory myopathies.
METHODS: Immunohistochemical staining of skeletal muscle biopsies (10 DM, 10 SSc, 10 PM, 10 SLE, 10 non-inflammatory myopathies) for tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), activated caspase-1, pan-macrophage marker CD68, inducible nitric oxide synthase (NOS2) and nerve growth factor receptor (NGFR). TechMate staining robot and biotin-streptavidin protocol were used.
RESULTS: Expression of TNF-alpha, IL-1 beta, caspase-1 and NOS2 was found in the cytoplasm and sarcolemma of dystrophic skeletal muscle fibres. TNF-alpha and IL-1 beta immunoreactive profiles were faint and few and close to satellite nuclei-containing regenerating muscle fibres both in inflammatory and non-inflammatory myopathies. NGFR expression was found in comparable areas. In non-inflammatory inherited myopathies more nuclei were caspase-1 immunoreactive whereas caspase-1 expression was rarely seen in inflammatory myopathies, implying regeneration of the affected muscle fibres.
CONCLUSION: Prominent expression of the proinflammatory factors TNF-alpha, IL-1 beta and NOS2 and caspase-1 is associated with muscle fibre damage, albeit when expressed to a low degree these factors may, like NGFR, contribute to muscle regeneration and healing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673888

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury.

Authors:  Nakul P Thakore; Supriti Samantaray; Sookyoung Park; Kenkichi Nozaki; Joshua A Smith; April Cox; James Krause; Naren L Banik
Journal:  Neurochem Res       Date:  2015-08-20       Impact factor: 3.996

2.  Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.

Authors:  M Tucci; C Quatraro; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 3.  The role of resistin in inflammatory myopathies.

Authors:  Mária Filková; Ladislav Senolt; Jiří Vencovský
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

4.  NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight.

Authors:  A Agustí; M Morlá; J Sauleda; C Saus; X Busquets
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

Review 5.  Role of NLRP3 inflammasome in systemic sclerosis.

Authors:  Cong Lin; Zhixing Jiang; Ling Cao; Hejian Zou; Xiaoxia Zhu
Journal:  Arthritis Res Ther       Date:  2022-08-16       Impact factor: 5.606

6.  Resistin in idiopathic inflammatory myopathies.

Authors:  Mária Filková; Hana Hulejová; Klára Kuncová; Lenka Pleštilová; Lucie Andrés Cerezo; Heřman Mann; Martin Klein; Josef Zámečník; Steffen Gay; Jiří Vencovský; Ladislav Senolt
Journal:  Arthritis Res Ther       Date:  2012-05-11       Impact factor: 5.156

7.  Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease.

Authors:  Nour Erekat; Muhammed D Al-Jarrah
Journal:  Med Sci Monit       Date:  2018-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.